MedTrace Logo

Comparison Of iStent to Laser in Exfoliation Glaucoma Helsinki Study Group

NCT04635020 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2020-11-18

No results posted yet for this study

Summary

The purpose of the study is to investigate the efficacy of an iStent trabecular microbypass stent compared to selective laser trabeculoplasty in combination with cataract surgery in eyes with exfoliation glaucoma (EXF)

Conditions

  • Exfoliation Glaucoma
  • Cataract

Interventions

PROCEDURE

iStent

2 trabecular Stent injected at the end of the cataract surgery to the trabecular meshwork

PROCEDURE

SLT-laser

1 month after cataract surgery laser treatment to the trabecular meshwork (100 applications, 360 degrees)

PROCEDURE

Cataract surgery

Conventional cataract surgery

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Mika Harju, MD, prof. · Helsinki University Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-09-30
Completion
2033-09-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04635020 on ClinicalTrials.gov